EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis: three diagnostic pathways and a preventable diagnostic odyssey

Yang Dai, Yushuang Xiao, Ruilian Xie, Xushu Zhong, Yijun Wu, Ailin Zhao, Ting Niu

Frontiers in Immunology · 16.11.2026 · 17

DOI: 10.3389/fimmu.2026.2008773 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Immunology, online erschienen am 16.11.2026. Verfasst von Yang Dai und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral leishmaniasis (VL) can trigger hemophagocytic lymphohistiocytosis (HLH), but the substantial overlap between severe leishmaniasis and the clinical criteria for HLH can obscure the underlying infection and delay pathogen-directed treatment, particularly in non-endemic settings. We describe three adults with VL-associated HLH who reached the same diagnosis through three distinct pathways. In the first patient, Leishmania amastigotes were identified on bone marrow smear during the evaluation of HLH. In the second, peripheral-blood metagenomic next-generation sequencing (mNGS) detected Leishmania early in the infectious work-up, allowing antiparasitic treatment to begin before etoposide was administered. In the third, recurrent fever and massive splenomegaly persisted despite approximately three months of etoposide-based treatment for presumed refractory HLH, while positron emission tomography/computed tomography (PET/CT) raised concern for lymphoma; the diagnosis was ultimately established by splenic biopsy and repeat bone marrow examination demonstrating Leishmania. Following antileishmanial therapy, all three patients showed resolution of fever and improvement of cytopenias, hyperferritinemia, and organomegaly, and no further HLH-directed cytotoxic chemotherapy was required after the infectious diagnosis was established. Together, these cases illustrate that VL may both mimic and drive the HLH phenotype, creating a potentially preventable diagnostic delay when the infectious cause is not considered early. Careful residence and travel history, together with timely pathogen-directed testing such as serology, bone marrow examination, and peripheral-blood mNGS when available, can facilitate earlier recognition. In suspected infection-associated HLH, identifying and treating the underlying pathogen is therefore central, while additional HLH-directed immunosuppressive therapy should be individualized according to the severity and persistence of hyperinflammation.

Zitieren

APA

Dai, Y., Xiao, Y., Xie, R., Zhong, X., Wu, Y., Zhao, A., & Niu, T. (2026). Case Report: Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis: three diagnostic pathways and a preventable diagnostic odyssey. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.2008773

Vancouver

Dai Y, Xiao Y, Xie R, Zhong X, Wu Y, Zhao A, et al. Case Report: Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis: three diagnostic pathways and a preventable diagnostic odyssey. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.2008773

BibTeX
@article{Dai2026,
  author = {Dai, Yang and Xiao, Yushuang and Xie, Ruilian and Zhong, Xushu and Wu, Yijun and Zhao, Ailin and Niu, Ting},
  title = {Case Report: Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis: three diagnostic pathways and a preventable diagnostic odyssey},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.2008773}
}
Kostenlos starten →